Back

TempraMed signs non-binding distribution agreement with CPO Cyprus

Verifying
  • TempraMed Technologies signed a non-binding letter of intent with CPO Cyprus.
  • CPO Cyprus would exclusively distribute VIVI Cap™ and VIVI Epi™.
  • The products are temperature-sensitive medications developed by TempraMed.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
TempraMed signs non-binding distribution agreement with CPO Cyprus - CoinPost Terminal